Concord Drugs Financials Statement

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Sep-2023	Jun-2023	Mar-2023	Dec-2022	Sep-2022
Gross Sales	7.52	8.98	12.31	13.53	13.72
Excise Duty	--	--	--	--	--
Net Sales	7.52	8.98	12.31	13.53	13.72
Other Operating Income	0.01	--	--	--	--
Other Income	--	--	--	--	--
Total Income	7.52	8.98	12.31	13.53	13.72
Total Expenditure	5.91	7.52	11.34	12.08	12.53
PBIDT	1.61	1.46	0.97	1.44	1.19
Interest	0.43	0.44	0.50	0.45	0.42
PBDT	1.19	1.02	0.47	1	0.77
Depreciation	0.39	0.38	0.33	0.38	0.53
Minority Interest Before NP	--	--	--	--	--
Tax	0.25	0.18	0.05	0.17	0.09
Deferred Tax	(0.01)	(0.03)	(0.08)	(0.01)	(0.03)
Reported Profit After Tax	0.56	0.49	0.16	0.45	0.18
Minority Interest After NP	--	--	--	--	--
Net Profit after Minority Interest	0.56	0.49	0.16	0.45	0.18
Extra-ordinary Items	--	--	--	--	--
Adjusted Profit After Extra-ordinary item	0.56	0.49	0.16	0.45	0.18
EPS (Unit Curr.)	0.60	0.53	0.17	0.52	0.21
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	9.32	9.32	9.32	8.74	8.74
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	21.41	16.26	7.88	10.64	8.67
PBDTM(%)	15.82	11.36	3.82	7.39	5.61
PATM(%)	7.45	5.46	1.30	3.33	1.31

QuickLinks for Concord Drugs Ltd.